Net profit of Eagle Pharmaceuticals under GAAP for 9 months of 2020 amounted to $3,932 million, which is 4.3 times less than $13,308 million in the previous year. Revenue decreased by 6.6% to $137.886 million against $147.634 million a year earlier.